Retirement Planning Company of New England’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,226
Closed -$705K 216
2024
Q1
$705K Buy
3,226
+373
+13% +$82.2K 0.39% 80
2023
Q4
$648K Buy
2,853
+381
+15% +$80K 0.29% 102
2023
Q3
$497K Sell
2,472
-949
-28% -$200K 0.28% 101
2023
Q2
$709K Buy
3,421
+65
+2% +$12.6K 0.41% 80
2023
Q1
$661K Buy
3,356
+90
+3% +$18.5K 0.4% 81
2022
Q4
$661K Sell
3,266
-260
-7% -$50.8K 0.43% 75
2022
Q3
$620K Buy
3,526
+156
+5% +$31.9K 0.45% 74
2022
Q2
$678K Buy
3,370
+318
+10% +$67.8K 0.46% 72
2022
Q1
$691K Buy
3,052
+998
+49% +$235K 0.39% 77
2021
Q4
$554K Buy
+2,054
New +$508K 0.27% 103

Other funds holding LH

Retirement Planning Company of New England's LH Position: Q2 2024 in Review

Retirement Planning Company of New England sold out of Labcorp (LH) in Q2 2024, closing a stake of 3,226 shares — an estimated $705K sold.

Retirement Planning Company of New England first reported a position in LH in Q4 2021 and held it in 10 quarters. The position peaked at $709K in Q2 2023. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Retirement Planning Company of New England reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Retirement Planning Company of New England sold 3,226 Labcorp shares in Q2 2024, an estimated $705K.
  • Retirement Planning Company of New England first reported a position in Labcorp in Q4 2021 and held it in 10 quarters.
  • Retirement Planning Company of New England's Labcorp position peaked at $709K in Q2 2023.
  • 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Retirement Planning Company of New England's 13F filing for Q2 2024, filed 8 Aug 2024.